Tissuemed

Tissuemed Ltd.
Private
Industry Medical Devices
Headquarters Leeds, West Yorkshire, U.K.
Products TissuePatch product family of surgical sealant films
Website www.tissuemed.com

Tissuemed is a medical device developer and manufacturer based in Leeds, UK.

The company was founded in 1985 and developed the first tissue heart valve (derived from pigs) to receive regulatory approval (CE mark) in Europe. This business was divested in 1999 [1] and the heart values are currently sold by Vascutek, a Terumo company under the Aspire brand.[2][3] Thereafter Tissuemed focused on the development of innovative tissue adhesives for internal surgical use, including a light activated tissue sealant to prevent blood loss during vascular anastomosis, the TissueBond system.[4][5]

More recently in 2007, Tissuemed launched TissuePatch, a range of surgical sealant films for the prevention of leaks during surgery, including thoracic, general and neurosurgery.[6] [7]

These products incorporate a unique synthetic bioadhesive that forms a covalent bond with tissue proteins enabling adhesion to internal organs and achieving a sealing effect.

References

  1. ↑ AorTech buys TissueMed's heart valve division. Elservier Business Intelligence, 1999. http://www.elsevierbi.com/deals/199910268
  2. ↑ Kumar, P; Athanasiou T; Mussa S; Wood AJ. (2003). "Ten year experience with Aspire (Tissuemed) porcine bioprosthesis: single centre experience.". Cardiovascular Surgery 11 (2): 131–7. doi:10.1016/s0967-2109(03)00011-5. PMID 12664048.
  3. ↑ Goldsmith, IR; Spyt TJ; Boehm M; Kendall S; Rosin MD. (2001). "Midterm evaluation of the Tissuemed (Aspire) porcine bioprosthesis: 493 patients, 506 bioprostheses.". The Annals of Thoracic Surgery 71 (5): 1471–6. doi:10.1016/s0003-4975(01)02397-9. PMID 11383785.
  4. ↑ Birch, JF; Mandley DJ; Williams SL; Worrall DR; Trotter PJ; Wilkinson F; Bell PR. (2000). "Methylene blue based protein solder for vascular anastomoses: an in vitro burst pressure study.". Lasers in Surgery and Medicine 26 (3): 323–9. doi:10.1002/(sici)1096-9101(2000)26:3<323::aid-lsm11>3.0.co;2-r.
  5. ↑ US patent 6,239,190, "Enhancement of activation for biological tissue adhesives, bonding agents and sealants using "color change" chromophores", published 2001, assigned to Tissuemed Ltd
  6. ↑ Ferroli, P; Acerbi, F; Broggi, M; Schiariti, M; Albanese, E; Tringali, G; Franzini, A; Broggi, G (Mar–Apr 2013). "A novel impermeable adhesive membrane to reinforce dural closure: a preliminary retrospective study on 119 consecutive high-risk patients.". World Neurosurgery 79 (3-4): 551–7. doi:10.1016/j.wneu.2011.09.022. PMID 22120260.
  7. ↑ Schiariti M, Acerbi F, Broggi M, Tringali G, Raggi A, Broggi G, Ferroli P. Two alternative dural sealing techniques in posterior fossa surgery: (Polylactide-co-glycolide) self-adhesive resorbable membrane versus polyethylene glycol hydrogel. Surg Neurol Int. 2014 Dec 3;5:171. doi: 10.4103/2152-7806.146154.
This article is issued from Wikipedia - version of the Thursday, November 05, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.